Ascendis Pharma Stock

1 day agoAscendis Pharma AS on Wednesday said the US. Ascendis Pharma started at outperform with 180 stock price target at Evercore ISI Mar.

Ascendis Pharma Asnd Market Capitalization

14 hours agoShares of Ascendis Pharma AS are trading about 25 higher on Nasdaq Thursday following news the US.

Ascendis pharma stock. 14 hours agoBiotech Stock Surges After An FDA Approval Lands It In A Massive New Market Investors Business Daily Ascendis Pharma won FDA approval to treat children with insufficient growth hormone and the. Ascendis Pharma ASND - Get Report shares jumped on Thursday after the company said the US. The stock opened at 12071 on Monday and it wasnt until Wednesday that it.

The company said Skytrofa or. The stock opened with a gain of at 15057 and touched an intraday high of 15878 rising 2873 against the last close of 12334. The stock went to a low of 14613 during the session.

14 hours agoSee Why Ascendis Pharma Stock Is Shining On Thursday. Ascendis Pharma AS a biopharmaceutical company develops therapeutics for unmet medical needs. Ascendis Ascendis Pharma Ascendis Pharma logo the company logo and TransCon are trademarks owned by the Ascendis Pharma group.

Ascendis Pharma AS NASDAQASNDs traded shares stood at 118 million during the latest session with the companys beta value hitting 076. 25 2019 at 820 am. Press Release reported 18 hours ago that Ascendis Pharma AS Reports Second Qua.

Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency. Stock analysis for Ascendis Pharma AS ASNDNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. The ASND shares 52-week high r.

In that particular session Stock kicked-off at the price of 12190 while reaching the peak value of 124398 and lowest value recorded on the day was 11962. ASND long-acting growth hormone lonapegsomatropin-tcgd. Quant What is the blockchains first operating system.

The FDA on Wednesday gave a thumbs-up to Ascendis Pharma ASs NASDAQ. The company develops TransCon growth hormone which completed Phase III clinical. ET by Tomi Kilgore Ascendis Pharma stock price target raised to 217 from 81 at Wedbush.

Ascendis Pharma AS NASDAQASND went up by 2661 from its latest closing price compared to the recent 1-year high of 18398. Food and Drug Administration approved Skytrofa its once-weekly treatment for pediatric growth hormone. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone.

4 hours agoShares of Ascendis Pharma NASDAQASND climbed more than 25 this week almost all of that on Thursday. As of June 30 2021 Ascendis Pharma had cash cash equivalents and marketable securities of 6413 million compared to 7711 million as of March 31 2021. Ascendis Pharma We apply our TransCon technology platform to build a leading fully integrated biopharma company make a meaningful difference for patients caregivers HCPs.

Change Volume Todays Open Previous Close. Todays High Todays Low 52 Week High 52 Week Low. The companys stock price has collected 343 of gains in the last five trading sessions.

At the last check today the stocks price was 15405 to imply an increase of 2457 or 3038 in intraday trading. 14 hours agoThe FDA on Wednesday gave a thumbs-up to Ascendis Pharma ASs ASND 2256 long-acting growth hormone lonapegsomatropin-tcgd. 5 hours agoAscendis Pharma AS ASND stock rallied over 2137 intraday to trade at 14970 share on Nasdaq.

As of June 30 2021 Ascendis Pharma had 53900990 ordinary shares outstanding. Stock Quote Chart Stock Quote Chart Stock Quote. Marketed as Skytrofa the somatropin prodrug has been approved in kids.

The stock current value is 15399Recently in New. At the end of the latest market close Ascendis Pharma AS ASND was valued at 12367.

Ascendis Shares Volatile Ahead Of Possible Restructuring Deal